Younis J S, Ezra Y, Sherman Y, Simon A, Schenker J G, Laufer N
In Vitro Fertilization Unit, Hadassah University Hospitals, Jerusalem, Israel.
Fertil Steril. 1994 Jul;62(1):103-7. doi: 10.1016/s0015-0282(16)56823-x.
To examine whether luteal E2 is obligatory for obtaining an adequately developed endometrium.
Survey of women with premature ovarian failure (POF) in a prospective, controlled, randomized study.
In vitro fertilization unit in a tertiary care university medical center.
Fourteen amenorrheic women with POF, candidates for oocyte donation, were divided into two distinct groups with seven women in each subgroup.
Endometrial priming with a fixed dose of oral micronized E2, 4 mg/d for 14 days, was similarly performed in the study and the control groups. Progesterone replacement during the luteal phase was also identical in the two groups and was accomplished by IM P in oil, 50 mg/d for another 14 days. Only the control group continued to have the same E2 regimen during the luteal phase.
Follicular phase mean E2 levels as well as luteal phase mean P levels were similar in both groups. However, luteal E2 levels differed significantly between the study and the control groups (21 +/- 5 and 692 +/- 199 pg/mL, respectively; conversion factor to SI units, 3.671). Nevertheless, histologic evaluation of endometrial biopsies on days 21 and 26 were similar for both groups. Endometrial gland dating, using light microscopy in the study and the control groups, on day 21, was 19.1 +/- 0.8 and 18.4 +/- 0.5, respectively, and on day 26, 25.4 +/- 0.8 and 25.9 +/- 0.5, respectively. Dating of the stroma in the two biopsies was also similar in both groups. Moreover, transmission electron microscopy performed in two patients of the study group showed typical characteristics of a secretory endometrium.
Luteal E2 depletion in the human does not seem to adversely affect the morphological developmental capacity of the endometrium. Our results suggest that E2 secretion by the corpus luteum in the human does not appear to be obligatory for the development of a normal secretory endometrium. The actual receptivity of the endometrium after such preparation needs to be evaluated.
研究黄体期雌二醇(E2)对于获得充分发育的子宫内膜是否必不可少。
在前瞻性、对照、随机研究中对卵巢早衰(POF)女性进行调查。
三级护理大学医学中心的体外受精单元。
14名闭经的POF女性,卵母细胞捐赠候选者,分为两个不同的组,每个亚组7名女性。
研究组和对照组均以固定剂量口服微粒化E2(4mg/d,共14天)进行子宫内膜预处理。两组黄体期的孕酮替代治疗也相同,通过肌内注射油剂黄体酮(50mg/d,持续14天)完成。只有对照组在黄体期继续采用相同的E2治疗方案。
两组的卵泡期平均E2水平以及黄体期平均孕酮(P)水平相似。然而,研究组和对照组的黄体期E2水平差异显著(分别为21±5和692±199pg/mL;换算为国际单位制的转换因子为3.671)。尽管如此,两组在第21天和第26天的子宫内膜活检组织学评估相似。研究组和对照组在第21天使用光学显微镜进行的子宫内膜腺体分期分别为19.1±0.8和18.4±0.5,在第26天分别为25.4±0.8和25.9±0.5。两组两次活检的基质分期也相似。此外,对研究组两名患者进行的透射电子显微镜检查显示出分泌期子宫内膜的典型特征。
人体黄体期E2缺乏似乎不会对子宫内膜的形态发育能力产生不利影响。我们的结果表明,人体黄体分泌E2似乎并非正常分泌期子宫内膜发育所必需。这种预处理后子宫内膜的实际容受性需要评估。